These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11606748)

  • 1. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.
    Sivaraman L; Conneely OM; Medina D; O'Malley BW
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12379-84. PubMed ID: 11606748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.
    Guzman RC; Yang J; Rajkumar L; Thordarson G; Chen X; Nandi S
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2520-5. PubMed ID: 10051675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.
    Rajkumar L; Kittrell FS; Guzman RC; Brown PH; Nandi S; Medina D
    Breast Cancer Res; 2007; 9(1):R12. PubMed ID: 17257424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of parity on rat mammary carcinogenesis after pre- or post-pubertal exposure to radiation.
    Takabatake M; Daino K; Imaoka T; Blyth BJ; Kokubo T; Nishimura Y; Showler K; Hosoki A; Moriyama H; Nishimura M; Kakinuma S; Fukushi M; Shimada Y
    Sci Rep; 2018 Sep; 8(1):14325. PubMed ID: 30254198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of khat (Catha edulis) and oral contraceptive use on telomerase levels and tumor suppressor genes p53 and p21 in normal subjects and breast cancer patients.
    Atroosh F; Al-Habori M; Al-Eryani E; Saif-Ali R
    Sci Rep; 2024 Jul; 14(1):16365. PubMed ID: 39013992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Function and Dysfunction in Human Health and Diseases.
    D'Orazi G
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.
    Miller JL; Bartlett AP; Harman RM; Majhi PD; Jerry DJ; Van de Walle GR
    J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):185-210. PubMed ID: 35904679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Senescence in Normal Mammary Gland and Breast Cancer. Implications for Cancer Therapy.
    Sirinian C; Peroukidis S; Kriegsmann K; Chaniotis D; Koutras A; Kriegsmann M; Papanastasiou AD
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Social Enrichment Modulates Tumor Progression and p53 Expression in Adult Mice.
    Middei S; Giorgini L; Vacca V; Storri F; Putti S; Strimpakos G; Raspa M; Scavizzi F; Moretti F; D'Amato FR
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Sex in the Therapeutic Targeting of p53 Circuitry.
    Mancini F; Giorgini L; Teveroni E; Pontecorvi A; Moretti F
    Front Oncol; 2021; 11():698946. PubMed ID: 34307167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nkx2.5 Functions as a Conditional Tumor Suppressor Gene in Colorectal Cancer Cells
    Li H; Wang J; Huang K; Zhang T; Gao L; Yang S; Yi W; Niu Y; Liu H; Wang Z; Wang G; Tao K; Wang L; Cai K
    Front Oncol; 2021; 11():648045. PubMed ID: 33869046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.
    Horwitz KB; Sartorius CA
    J Mol Endocrinol; 2020 Jul; 65(1):T49-T63. PubMed ID: 32485679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions.
    Feigman MJ; Moss MA; Chen C; Cyrill SL; Ciccone MF; Trousdell MC; Yang ST; Frey WD; Wilkinson JE; Dos Santos CO
    Nat Commun; 2020 May; 11(1):2649. PubMed ID: 32461571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer.
    Nguyen B; Venet D; Lambertini M; Desmedt C; Salgado R; Horlings HM; Rothé F; Sotiriou C
    Breast Cancer Res; 2019 Feb; 21(1):25. PubMed ID: 30770770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.
    Gandhi N; Das GM
    Cells; 2019 Jan; 8(2):. PubMed ID: 30691108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.
    McGowan EM; Lin Y; Hatoum D
    Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29857525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.
    Boonyaratanakornkit V; Hamilton N; Márquez-Garbán DC; Pateetin P; McGowan EM; Pietras RJ
    Mol Cell Endocrinol; 2018 May; 466():51-72. PubMed ID: 29146555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the p53-tristetraprolin-stathmin-1 pathway on trophoblasts at maternal-fetal interface.
    Ma XL; Li XC; Tian FJ; Zhang SM; Liu XR; Zhang Y; Fan JX; Lin Y
    PLoS One; 2017; 12(6):e0179852. PubMed ID: 28658321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
    Zhang Y; Wu YY; Qiao FY; Zeng WJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of parity and serum prolactin levels on the incidence and regression of DMBA-induced tumors in OFA hr/hr rats.
    Sasso CV; Santiano FE; López-Fontana CM; Pistone-Creydt V; Ezquer ME; Hapon MB; Jahn GA; Carón RW
    Biomed Res Int; 2014; 2014():210424. PubMed ID: 25136563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.